MoneyWorks4Me

Kopran - Quaterly Results

07 Nov 2023 Evaluate
An increase of about 83.95% to Rs. 986.39 millions in the topline was observed for the quarter ended September 2023. The topline stood at Rs. 536.23 millions during the similar quarter previous year.Profit after Tax for the quarter ended September 2023 saw a decline of -40.39% from Rs. 178.87 millions to Rs. 106.63  millions.Operating Profit reported a sharp decline to 144.91 millions from 206.43 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 986.39 536.23 83.95 1644.99 1248.03 31.81 2730.95 2045.20 33.53
Other Income 57.89 147.38 -60.72 72.71 149.11 -51.24 160.86 80.27 100.40
PBIDT 144.91 206.43 -29.80 167.93 272.99 -38.48 439.99 234.40 87.71
Interest 7.45 6.13 21.53 16.97 11.08 53.16 26.72 29.53 -9.52
PBDT 137.46 200.30 -31.37 150.96 261.91 -42.36 413.27 204.87 101.72
Depreciation 11.63 11.23 3.56 22.87 22.04 3.77 44.12 43.23 2.06
PBT 125.83 189.07 -33.45 128.09 239.87 -46.60 369.15 161.64 128.38
TAX 19.20 10.20 88.24 19.92 22.96 -13.24 56.63 44.20 28.12
Deferred Tax -0.08 -1.74 -95.40 -0.63 -2.76 -77.17 -2.09 6.73 -131.05
PAT 106.63 178.87 -40.39 108.17 216.91 -50.13 312.52 117.44 166.11
Equity 482.11 482.11 0.00 482.11 482.11 0.00 482.12 482.12 0.00
PBIDTM(%) 14.69 38.50 -61.84 10.21 21.87 -53.33 16.11 11.46 40.57
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..